News
A caregiver needs respite from the duties of watching over a chronically ill patient, columnist Cazandra Campos-MacDonald writes.
The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...
Columnist Alliah Czarielle says her husband, Jared, adapts to whatever hemophilia and epilepsy throw his way. Being present is the core.
Successful immune tolerance induction (ITI) in hemophilia A patients with inhibitors led to lower treatment costs, a study ...
Columnist Jennifer Lynne argues that her health is not defined by her diagnoses, and in fact those terms can often be too limited.
Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results